These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27934478)

  • 21. In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer.
    Shan X; Liu C; Yuan Y; Xu F; Tao X; Sheng Y; Zhou H
    Colloids Surf B Biointerfaces; 2009 Sep; 72(2):303-11. PubMed ID: 19450955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages.
    Benne CA; Benaissa-Trouw B; van Strijp JA; Kraaijeveld CA; van Iwaarden JF
    Eur J Immunol; 1997 Apr; 27(4):886-90. PubMed ID: 9130640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
    Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
    Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surfactant protein A modulates release of reactive oxygen species from alveolar macrophages.
    Weissbach S; Neuendank A; Pettersson M; Schaberg T; Pison U
    Am J Physiol; 1994 Dec; 267(6 Pt 1):L660-6. PubMed ID: 7810671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages.
    Tino MJ; Wright JR
    Am J Physiol; 1996 Apr; 270(4 Pt 1):L677-88. PubMed ID: 8928829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of immunohistochemical staining with pulmonary surfactant protein A among fractionated alveolar macrophages which involves metabolism of pulmonary surfactant.
    Sakai K; Kohri T; Kawaguchi Y; Kweon MN; Kishino Y
    Cell Mol Biol (Noisy-le-grand); 1992 Dec; 38(8):853-60. PubMed ID: 1477601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant protein A is degraded by alveolar macrophages.
    Bates SR; Fisher AB
    Am J Physiol; 1996 Aug; 271(2 Pt 1):L258-66. PubMed ID: 8770065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Size-dependent internalisation of folate-decorated nanoparticles via the pathways of clathrin and caveolae-mediated endocytosis in ARPE-19 cells.
    Langston Suen WL; Chau Y
    J Pharm Pharmacol; 2014 Apr; 66(4):564-73. PubMed ID: 24635558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol).
    Zahr AS; Davis CA; Pishko MV
    Langmuir; 2006 Sep; 22(19):8178-85. PubMed ID: 16952259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
    Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and biodisposition of methoxypolyethylene glycol amine-poly(DL-lactic acid) copolymer nanoparticles loaded with pyrene-ended poly(DL-lactic acid).
    Sasatsu M; Onishi H; Machida Y
    Int J Pharm; 2008 Jun; 358(1-2):271-7. PubMed ID: 18448290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surface tension influences cell shape and phagocytosis in alveolar macrophages.
    Akei H; Whitsett JA; Buroker M; Ninomiya T; Tatsumi H; Weaver TE; Ikegami M
    Am J Physiol Lung Cell Mol Physiol; 2006 Oct; 291(4):L572-9. PubMed ID: 16632521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages.
    Chono S; Kaneko K; Yamamoto E; Togami K; Morimoto K
    Drug Dev Ind Pharm; 2010 Jan; 36(1):102-7. PubMed ID: 19656002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages.
    Williams MD; Wright JR; March KL; Martin WJ
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):232-8. PubMed ID: 8845173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B.
    Jain AK; Goyal AK; Gupta PN; Khatri K; Mishra N; Mehta A; Mangal S; Vyas SP
    J Control Release; 2009 Jun; 136(2):161-9. PubMed ID: 19239919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A.
    Elhalwagi BM; Zhang M; Ikegami M; Iwamoto HS; Morris RE; Miller ML; Dienger K; McCormack FX
    Am J Respir Cell Mol Biol; 1999 Sep; 21(3):380-7. PubMed ID: 10460755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary surfactant protein A enhances endolysosomal trafficking in alveolar macrophages through regulation of Rab7.
    Sender V; Moulakakis C; Stamme C
    J Immunol; 2011 Feb; 186(4):2397-411. PubMed ID: 21248257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging.
    Kumagai M; Imai Y; Nakamura T; Yamasaki Y; Sekino M; Ueno S; Hanaoka K; Kikuchi K; Nagano T; Kaneko E; Shimokado K; Kataoka K
    Colloids Surf B Biointerfaces; 2007 Apr; 56(1-2):174-81. PubMed ID: 17324561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.